Search

Search Constraints

You searched for: Author/Creator Beigel, John H

Search Results

1. 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). (15th December 2022)

2. 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir. (15th December 2022)

3. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Issue 11 (November 2019)

4. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. Issue 11 (November 2019)

5. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Issue 9 (September 2022)

6. Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations. (14th March 2019)

7. Comparison of Rates of Hospitalization Between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults With Influenza-Like Illness. (3rd October 2019)

8. Different Clinical Presentations of Human Rhinovirus Species Infection in Children and Adults in Mexico. (17th June 2022)

9. Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial. (27th July 2019)

10. Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness. (7th February 2019)